ESMO open
KRAS mutations in colorectal cancer patients receiving trifluridine/tipiracil plus bevacizumab: something to consider.
A Rizzo, O Brunetti, G Brandi
Published: 202510.1016/j.esmoop.2025.105900
No abstract available for this study.
A Rizzo, O Brunetti, G Brandi
No abstract available for this study.